Literature DB >> 3774383

Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia.

R Sosulski, S Abbasi, V K Bhutani, W W Fox.   

Abstract

This study defines the physiologic changes in pulmonary mechanics induced by subcutaneous terbutaline administration in ventilator-dependent infants with severe bronchopulmonary dysplasia (BPD). Eight such infants (mean +/- SEM weight = 2.56 +/- 0.32 kg, postnatal age = 13.0 +/- 3.2 weeks) were chosen for the study. Pulmonary mechanics and arterial blood gases were measured in the control state and at 30 and 60 minutes following the subcutaneous injection of 5 micrograms/kg terbutaline. There was a significant (p less than 0.001) improvement in lung compliance from baseline values at 30 minutes and at 60 minutes (38%). A significant (p less than 0.05) decrease of 23% in the average pulmonary resistance at 30 minutes and a 26% decrease at 60 minutes from control values were observed. An increase in the I/E ratio occurred in all patients at 60 minutes (p less than 0.01). In addition, clinical improvement was noted in six of eight infants. Administration of terbutaline demonstrated a significant improvement in the pulmonary mechanics of infants with severe BPD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3774383     DOI: 10.1002/ppul.1950020504

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Effective bronchodilator treatment by a simple spacer device for wheezy premature infants.

Authors:  B Yuksel; A Greenough; I Maconochie
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Early detection of lung function abnormalities in infants with cystic fibrosis.

Authors:  R Kraemer
Journal:  J R Soc Med       Date:  1989       Impact factor: 5.344

3.  Dose-response relationships and time course of the response to systemic beta adrenoreceptor agonists in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; M H Schöni
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

4.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases.

Authors:  R Kraemer; P Birrer; F H Sennhauser; M H Schöni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?

Authors:  Rishika P Sakaria; Ramasubbareddy Dhanireddy
Journal:  Front Pediatr       Date:  2022-03-09       Impact factor: 3.418

7.  Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants.

Authors:  Joshua C Euteneuer; Ellen Kerns; Chelsey Leiting; Russell J McCulloh; Eric S Peeples
Journal:  J Perinatol       Date:  2020-08-05       Impact factor: 2.521

8.  Respiratory response to salbutamol (albuterol) in ventilator-dependent infants with chronic lung disease: pressurized aerosol delivery versus intravenous injection.

Authors:  J Pfenninger; C Aebi
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.